I reckon it's not the relationship that's watertight, it's the contract. My facts may be blurry, but -
As I understand it, that contract for 25 years exclusivity takes effect from a certain milestone - maybe the day we get approval to market from the FDA. Also, we use the injectable PPS so they can freely continue to market other forms.
I could be way off the mark here, just my thoughts.
research reports and media, page-4103
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
55.5¢ |
Change
0.015(2.78%) |
Mkt cap ! $216.0M | |||
| Open | High | Low | Value | Volume |
| 55.0¢ | 57.0¢ | 53.0¢ | $1.578M | 2.857M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 25951 | 55.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 55.5¢ | 43471 | 1 |
View Market Depth
| Last trade - 16.10pm 30/01/2025 (20 minute delay) ? |
| PAR (ASX) Chart |